Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: Cancer Genet Cytogenet. 2008 Feb;181(1):8–15. doi: 10.1016/j.cancergencyto.2007.10.008

Figure 4. Gene signature of DLBCL dichotomized by the expression of miR-155.

Figure 4

The 100 probe sets that more strongly correlate with miR-155 expression in 88 DLBCLs are shown. Gene ranks are based on signal-to-noise metrics and red or blue indicate high or low expression, respectively. Each column is a tumor and each row a gene. The genes consistently downregulated in DLBCL expressing high miR-155 levels are shown of the upper right quadrant. The predicted miR-155 targets, distributed throughout this ranked group, are indicated (in bold are those predicted by multiple models). Expectedly, expression of MiR-155, indicated on the left, drives the distinction between these two DLBCL groups.